IOL Chemicals [IOLCP] vs Innova Captab [INNOVACAP] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: IOL Chemicals and Pharmaceuticals Ltd. wins in 9 metrics, Innova Captab Ltd. wins in 11 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | IOL Chemicals and Pharmaceuticals Ltd. | Innova Captab Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.83 | 31.20 | IOL Chemicals and Pharmaceuticals Ltd. |
| Price-to-Book Ratio | 1.58 | 4.05 | IOL Chemicals and Pharmaceuticals Ltd. |
| Debt-to-Equity Ratio | 9.08 | 32.95 | IOL Chemicals and Pharmaceuticals Ltd. |
| PEG Ratio | 18.10 | 1.33 | Innova Captab Ltd. |
| EV/EBITDA | 11.58 | 20.49 | IOL Chemicals and Pharmaceuticals Ltd. |
| Profit Margin (TTM) | 5.20% | 8.85% | Innova Captab Ltd. |
| Operating Margin (TTM) | 6.39% | 12.88% | Innova Captab Ltd. |
| EBITDA Margin (TTM) | 6.39% | 12.88% | Innova Captab Ltd. |
| Return on Equity | 5.99% | 13.37% | Innova Captab Ltd. |
| Return on Assets (TTM) | 4.24% | 8.12% | Innova Captab Ltd. |
| Free Cash Flow (TTM) | $-349.30M | $-1.09B | IOL Chemicals and Pharmaceuticals Ltd. |
| Dividend Yield | 1.56% | 0.30% | IOL Chemicals and Pharmaceuticals Ltd. |
| 1-Year Return | 51.26% | 3.87% | IOL Chemicals and Pharmaceuticals Ltd. |
| Price-to-Sales Ratio (TTM) | 1.24 | 2.76 | IOL Chemicals and Pharmaceuticals Ltd. |
| Enterprise Value | $27.55B | $43.41B | Innova Captab Ltd. |
| EV/Revenue Ratio | 1.24 | 2.90 | IOL Chemicals and Pharmaceuticals Ltd. |
| Gross Profit Margin (TTM) | 34.11% | 35.19% | Innova Captab Ltd. |
| Revenue per Share (TTM) | $76 | $262 | Innova Captab Ltd. |
| Earnings per Share (Diluted) | $3.95 | $23.16 | Innova Captab Ltd. |
| Beta (Stock Volatility) | 0.03 | -0.33 | Innova Captab Ltd. |
IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| IOL Chemicals and Pharmaceuticals Ltd. | -0.54% | 5.20% | 26.03% | 94.47% | 61.90% | 62.47% |
| Innova Captab Ltd. | 0.58% | 8.95% | 10.45% | 34.08% | 34.58% | 28.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| IOL Chemicals and Pharmaceuticals Ltd. | 51.26% | 50.19% | 8.16% | 401.08% | 1,759.28% | 1,189.53% |
| Innova Captab Ltd. | 3.87% | 74.08% | 74.08% | 74.08% | 74.08% | 74.08% |
Performance & Financial Health Analysis: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.
| Metric | IOLCP | INNOVACAP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹27.17B | ₹41.43B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,912,191 | 578,151 |
| 90 Day Avg. Volume | 1,858,936 | 217,693 |
| Last Close | ₹133.52 | ₹947.95 |
| 52 Week Range | ₹67.19 - ₹139.99 | ₹622.00 - ₹978.00 |
| % from 52W High | -4.62% | -3.07% |
| All-Time High | ₹179.78 (Aug 24, 2020) | ₹1,260.00 (Jan 06, 2025) |
| % from All-Time High | -25.73% | -24.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.42% |
| Quarterly Earnings Growth | 0.00% | 0.23% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.09% |
| Operating Margin (TTM) | 0.06% | 0.13% |
| Return on Equity (TTM) | 0.06% | 0.13% |
| Debt to Equity (MRQ) | 9.08 | 32.95 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹59.60 | ₹178.28 |
| Cash per Share (MRQ) | ₹5.84 | ₹10.22 |
| Operating Cash Flow (TTM) | ₹1.67B | ₹282.88M |
| Levered Free Cash Flow (TTM) | ₹1.01B | ₹1.28B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.56% | 0.30% |
| Last 12-Month Dividend | ₹1.16 | ₹2.00 |
Valuation & Enterprise Metrics Analysis: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.
| Metric | IOLCP (Apr 24, 2026) | INNOVACAP (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.83 | 31.20 |
| Forward P/E | 18.10 | 21.90 |
| PEG Ratio | 18.10 | 1.33 |
| Price to Sales (TTM) | 1.24 | 2.76 |
| Price to Book (MRQ) | 1.58 | 4.05 |
| Market Capitalization | ||
| Market Capitalization | ₹27.17B | ₹41.43B |
| Enterprise Value | ₹27.55B | ₹43.41B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.24 | 2.90 |
| Enterprise to EBITDA | 11.58 | 20.49 |
| Risk & Other Metrics | ||
| Beta | 0.03 | -0.33 |
| Book Value per Share (MRQ) | ₹59.60 | ₹178.28 |
Financial Statements Comparison: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | IOLCP (2025) | INNOVACAP (2025) |
|---|---|---|
| Revenue/Sales | 20.68B | 12.34B |
| Cost of Goods Sold | 14.14B | 8.38B |
| COGS % of Revenue | 68.4% | 67.9% |
| Gross Profit | 6.54B | 3.96B |
| Gross Margin | 31.6% | 32.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 1.31B | 1.65B |
| Operating Margin | 6.3% | 13.4% |
| EBITDA | 2.19B | 2.00B |
| EBITDA Margin | 10.6% | 16.2% |
| Pre-Tax Income | 1.38B | 1.71B |
| Pre-Tax Income % of Revenue | 6.7% | 13.9% |
| Income Tax | 368.90M | 427.58M |
| Income Tax % of Revenue | 1.8% | 3.5% |
| Net Income (Profit) | 1.01B | 1.28B |
| Profit Margin | 4.9% | 10.4% |
Balance Sheet & Liquidity Metrics
| Metric | IOLCP (2025) | INNOVACAP (2025) |
|---|---|---|
| Cash & Equivalents | 781.70M | 155.19M |
| Total Current Assets | 11.51B | 7.03B |
| Total Current Assets % of Revenue | 55.7% | 57.0% |
| Total Current Liabilities | 6.10B | 3.53B |
| Total Current Liabilities % of Revenue | 29.5% | 28.6% |
| Long-Term Debt | 0 | 2.45B |
| Long-Term Debt % of Revenue | 0.0% | 19.8% |
| Total Shareholders Equity | 16.88B | 9.59B |
| Retained Earnings | 14.02B | 4.53B |
| Retained Earnings % of Revenue | 67.8% | 36.7% |
| Property, Plant & Equipment | 5.30M | 442.93M |
Cash Flow Statement Comparison
| Metric | IOLCP (2025) | INNOVACAP (2025) |
|---|---|---|
| Operating Cash Flow | 1.67B | 282.88M |
| Operating Cash Flow % of Revenue | 8.1% | 2.3% |
| Capital Expenditures | -2.13B | -1.72B |
| Free Cash Flow | -349.30M | -1.09B |
| FCF Margin | -1.7% | -8.8% |
| Debt Repayment | N/A | -114.03M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IOLCP | INNOVACAP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 293.53M | 57.22M |
| Float Shares | 83.67M | 15.91M |
| % Held by Insiders | 63.11% | 72.19% |
| % Held by Institutions | 1.29% | 19.22% |
| % Held by Public | 35.60% | 8.59% |
Dividend Analysis & Yield Comparison: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.
| Metric | IOLCP | INNOVACAP |
|---|---|---|
| Last 12-Month Dividend | ₹1.16 | ₹2.00 |
| Last 12-Month Dividend Yield | 1.56% | 0.30% |
| 3-Year Avg Annual Dividend | ₹0.45 | ₹0.67 |
| 3-Year Avg Dividend Yield | 0.60% | 0.30% |
| 3-Year Total Dividends | ₹1.36 | ₹2.00 |
| Ex-Dividend Date | Feb 17, 2026 | Jan 30, 2026 |